Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-062675
Filing Date
2015-11-04
Accepted
2015-11-04 11:31:28
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v422879_10q.htm 10-Q 359198
2 EXHIBIT 31.1 v422879_ex31-1.htm EX-31.1 11286
3 EXHIBIT 31.2 v422879_ex31-2.htm EX-31.2 11346
4 EXHIBIT 32.1 v422879_ex32-1.htm EX-32.1 5479
  Complete submission text file 0001144204-15-062675.txt   4252922

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ecyt-20150930.xml EX-101.INS 1228651
6 XBRL TAXONOMY EXTENSION SCHEMA ecyt-20150930.xsd EX-101.SCH 27557
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ecyt-20150930_cal.xml EX-101.CAL 28131
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ecyt-20150930_def.xml EX-101.DEF 183299
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ecyt-20150930_lab.xml EX-101.LAB 259395
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ecyt-20150930_pre.xml EX-101.PRE 222695
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 151195999
SIC: 2834 Pharmaceutical Preparations